Scinai Immunotherapeutics (SCNI) FCF Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) reported FCF Margin of 297.14% for Q1 2026, down 12103.0% on a YoY basis from N/an in Q1 2025, and up 63.71% sequentially from 818.72% in Q2 2025.
Scinai Immunotherapeutics (SCNI) FCF Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 3 years of FCF Margin data on file, last reported at 297.14% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 12103.0% year-over-year to 297.14%; the trailing twelve-month figure through Mar 2026 stood at 273.57% (changed N/A YoY), and the FY2025 full-year result was 253.45%, up 71114.0% from the prior year.
- FCF Margin grew to 297.14% in Q1 2026, from 818.72% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 176.11% in Q1 2025 to a low of 1210.71% in Q3 2024.
- A 3-year average of 607.33% and a median of 533.98% in 2024 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 12103 bps in 2026, while the deepest fall reached 12103 bps in 2026.
- Tracing SCNI's FCF Margin over 3 years: stood at 533.98% in 2024, then slumped by 53 bps to 818.72% in 2025, then jumped by 64 bps to 297.14% in 2026.
- Business Quant data shows SCNI's FCF Margin at 297.14% in Q1 2026, 818.72% in Q2 2025, and 176.11% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -297.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -297.14% |
| Jun 30, 2025 | -818.72% |
| Mar 31, 2025 | -176.11% |
| Dec 31, 2024 | -533.98% |
| Sep 30, 2024 | -1,210.71% |